Literature DB >> 11367531

Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells.

H L Schieferdecker1, G Schlaf, K Jungermann, O Götze.   

Abstract

Growing evidence obtained in recent years indicates that anaphylatoxin C5a receptors (C5aR) are not restricted to myeloid cells but are also expressed on nonmyeloid cells in different tissues such as brain, lung, skin and liver. In contrast to its well-defined systemic functions, the actions of anaphylatoxins in these organs are poorly characterized. The liver can be a primary target organ for the C5a anaphylatoxin since the liver is directly connected to the gut, via the mesenteric veins and portal vein which is a main source of complement activating lipopolysaccharides (LPS). In the normal rat liver, the C5aR is only expressed by nonparenchymal cells, i.e. strongly by Kupffer cells (KC) and hepatic stellate cells (HSC) and weakly by sinusoidal endothelial cells (SEC), but not expressed by the parenchymal hepatocytes (HC). Accordingly, direct effects of C5a were only found in the C5aR-expressing KC and HSC: C5a induced the release of prostanoids from KC and HSC and enhanced the LPS-dependent release of interleukin-6 from KC. These soluble mediators indirectly influenced effector functions of the C5aR-free HC. C5a enhanced the glycogen phosphorylase activity and thus the glucose output from HC indirectly via prostanoids released from KC and HSC. Glucose can serve as an energy substrate as well as an electron donor for the synthesis of reactive oxygen intermediates by KC. Moreover, C5a also enhanced transcription of the gene for the type-2 acute phase protein alpha 2-macroglobulin in HC indirectly by increasing LPS-dependent IL-6 release from KC. Under pathological conditions, C5aR was found to be upregulated in various organs including the liver. Simulation of inflammatory conditions by treatment of rats with IL-6, a main inflammatory mediator in the liver, caused a de novo expression of functional C5aR in HC. In livers of IL-6-treated rats, C5a initiated glucose output from HC and perhaps other HC-specific defense reactions directly without the intervention of soluble mediators from nonparenchymal cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11367531     DOI: 10.1016/s1567-5769(00)00038-2

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  22 in total

Review 1.  New insights into cellular mechanisms during sepsis.

Authors:  Laszlo M Hoesel; Hongwei Gao; Peter A Ward
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Redox signaling and the innate immune system in alcoholic liver disease.

Authors:  Jessica I Cohen; Xiaocong Chen; Laura E Nagy
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

3.  Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.

Authors:  Michele T Pritchard; Megan R McMullen; Feng Lin; M Edward Medof; Abram B Stavitsky; Jessica I Cohen; Laura E Nagy
Journal:  Gastroenterology       Date:  2007-02-01       Impact factor: 22.682

4.  Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.

Authors:  Toshihiko Nishimura; Timothy Myles; Adrian M Piliponsky; Adrian M Piliposky; Peter N Kao; Gerald J Berry; Lawrence L K Leung
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

5.  A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.

Authors:  Gaurav Mehta; Robert I Scheinman; V Michael Holers; Nirmal K Banda
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 6.  Alcohol and lipid metabolism.

Authors:  Margaret Sozio; David W Crabb
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-18       Impact factor: 4.310

7.  An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice.

Authors:  Sanjoy Roychowdhury; Megan R McMullen; Michele T Pritchard; Amy G Hise; Nico van Rooijen; M Edward Medof; Abram B Stavitsky; Laura E Nagy
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

8.  C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection.

Authors:  Yumi Nakayama; Shin-Il Kim; Eui Ho Kim; John D Lambris; Matyas Sandor; M Suresh
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

Review 9.  Kupffer cells in the liver.

Authors:  Laura J Dixon; Mark Barnes; Hui Tang; Michele T Pritchard; Laura E Nagy
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

10.  Complement 5a stimulates hepatic stellate cells in vitro, and is increased in the plasma of patients with chronic hepatitis B.

Authors:  Ruonan Xu; Fang Lin; Jin He; Lei Jin; Ji-Yuan Zhang; Junliang Fu; Honghong Liu; Siyu Wang; Zheng Zhang; Fu-Sheng Wang
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.